Thiotepa | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Thiotepa
US Patents

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Thiotepa

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 13 USDMF, 1 JDMF, 4 EU WC, 2 KDMF, 4 NDC API, 8 Listed Suppliers, $ API Reference Price

17 API Suppliers
13 USDMF
1 JDMF
4 EU WC
2 KDMF
4 NDC API
8 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

40 FDF Dossiers, 22 FDA Orange Book, 7 Europe, 6 Canada, 5 Listed Dossiers

40 FDF Dossiers
22 FDA Orange Book
7 Europe
6 Canada
5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL - 100MG/VIAL, POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL - 15MG/VIAL

POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL - 100MG/VIAL
POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL - 15MG/VIAL

DIGITAL CONTENT

8 News #PharmaBuzz

8 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 Regulatory FDF Prices

4 Regulatory FDF Prices

MARKET PLACE

4 APIs, 6 FDF Dossiers

4 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Patents

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

1 USP
1 Others

$ API Ref.Price (USD/KG) : 273,572 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2SHORLA

filter Patent Number Reset all filters

2 All

01 211975013

filter API Patent Reset all filters

2 All

01 2Blank

filter FDF Patent Reset all filters

2 All

01 2Y

filter Expiration Date Reset all filters

2 All

01 22041-08-16

Product Main Page

01

SHORLA

BePharma

Not Confirmed

SHORLA

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-08-16

US Patent Number : 11975013

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216984

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-08-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

SHORLA

BePharma

Not Confirmed

SHORLA

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-08-16

US Patent Number : 11975013

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216984

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-08-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!